Oversold

AZN

Same as last week
Valuation31/ 100
Cash flow & growth74/ 100
Upside potential25/ 100
Risk potential29/ 100

AZN's valuation is somewhat elevated, fundamentals are above averages and forward estimates point to improving growth and profitability, though analyst coverage is limited.

Valuation

Historical cheapness: current PE is 24.1× versus the full-history median of 18× shown in the valuation table, producing 31.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 30.5/100. The model applies a 8.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 15.9× (18-month half-life). The favorable scenario uses 21.1× PE and $7.9 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +8.6%, earnings +25.4%, operating margin +2.7 percentage points. Free cash flow is 14.2% of revenue. The business score is 73.7/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $7.86 of EPS and a 21.1× PE, suggesting about $165.92 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $184.20. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $5.58 of EPS and a 20.3× PE, suggesting a share price of about $113.05 — 29% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

AZN vs Historical averages

MetricCurrentAverageRelative
PE24x29x17% lower
PE percentile685036% higher
EPS$6.66$3.09116% higher
FCF$8.7B$6.3B38% higher
Loading historical comparisons…

AZN’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

AZN Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueGrowth
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionModerate

AZN’s outlook is generally improving, though analyst coverage is limited.

AZN PE Valuation

Loading pe valuation table…

This table applies AZN's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

AZN Earnings Per Share

Loading earnings per share…

This chart tracks AZN's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

AZN Quarterly Revenue

Loading quarterly revenue…

This chart tracks AZN's quarterly revenue over time and shows how sales are changing from year to year.

AZN Free Cash Flow

Loading free cash flow…

This chart tracks AZN's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

AZN Total Shares

Loading shares over time…

This chart tracks changes in AZN's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

AZN Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

AZN PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares AZN's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

AZN Weekly Price

Loading weekly price…

This chart uses AZN's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

AZN Weekly Moving Averages

Loading weekly moving averages…

This chart compares AZN's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

AZN Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

HIMS

Same as last week
Valuation50/ 100
Cash flow & growth51/ 100
Upside potential51/ 100
Risk potential60/ 100

HIMS's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to a return to profit and improving margins, though analyst coverage is limited and estimates vary widely.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +28%, operating margin -9.8 percentage points. Free cash flow is 3.5% of revenue. The business score is 50.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 63.4% upside, or about $44.95.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 38.1%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 59.9% downside, or about $11.03, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

HIMS vs Historical averages

MetricCurrentAverageRelative
PE50x81x39% lower
PE percentile215058% lower
EPS-$0.63-$0.12$0.50 lower
FCF$89.9M$42.3M112% higher
Loading historical comparisons…

HIMS’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

HIMS Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning positive
Forward revenueStrong growth
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionWide

HIMS’s outlook is generally improving, supported by an expected return to profitability.

HIMS PE Valuation

Loading pe valuation table…

This table applies HIMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

HIMS Earnings Per Share

Loading earnings per share…

This chart tracks HIMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

HIMS Quarterly Revenue

Loading quarterly revenue…

This chart tracks HIMS's quarterly revenue over time and shows how sales are changing from year to year.

HIMS Free Cash Flow

Loading free cash flow…

This chart tracks HIMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

HIMS Total Shares

Loading shares over time…

This chart tracks changes in HIMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

HIMS Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

HIMS PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares HIMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

HIMS Weekly Price

Loading weekly price…

This chart uses HIMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

HIMS Weekly Moving Averages

Loading weekly moving averages…

This chart compares HIMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

HIMS Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.